Atlas Trials

Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

Clinical trial NCT00251381 · UNKNOWN

Trial details

NCT number
NCT00251381
Sponsor
Trial Form Support S.L.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Oropharyngeal Neoplasms
Start date
2005-11-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.